Previous close | 12.50 |
Open | 31.31 |
Bid | 26.00 |
Ask | 35.80 |
Strike | 205.00 |
Expiry date | 2024-05-24 |
Day's range | 31.31 - 31.31 |
Contract range | N/A |
Volume | |
Open interest | 5 |
Biogen stock jumped Wednesday after the FDA gave its Eisai-partnered Alzheimer's treatment a fast track designation.
Biogen (BIIB) and Eisai start the rolling submission of a biologics license application to the FDA for Leqembi subcutaneous autoinjector as a weekly maintenance dosing regimen for early Alzheimer's disease.
Eli Lilly stock broke out and then retreated into sell-zone territory. With shares on the rise again, is LLY stock a buy?